# 2026-13534: FDA Seeks Comments on Paperwork Nobody Reads

2026-13534, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-07-06, effective Submit written comments (including recommendations) on the collection of information by August 5, 2026.; PRIA reads it as touching household money (as of 2026-07-13).

- Canonical: https://policyrisk.com/federal-register/2026-13534
- As of: 2026-07-13
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-13534
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 41040
- Published: 2026-07-06
- Effective: Submit written comments (including recommendations) on the collection of information by August 5, 2026.
- Comments close: 2026-08-05
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-13

## In one line

FDA Seeks Comments on Paperwork Nobody Reads

## Summary

The FDA is asking for public feedback on how it collects information for formal hearings and administrative rules. This affects businesses and people who interact with the FDA, with no new costs but a chance to improve paperwork processes. Comments are due by August 5, 2026, so don’t miss your chance to weigh in!

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

- Total FDA Paperwork Burden: 9,440 Hours: cost, medium. The FDA estimates the annual paperwork burden for these administrative practices and formal hearings at 9,440 total hours and states the collection reflects an increase of 3,080 annual burden hours. The agency also says there are no capital costs or operating and maintenance costs for this informat…
- Citizen Petitions: 24 Hours Each: cost, high. FDA estimates 330 citizen petitions or related petitions (including certain ANDAs, NDAs, and BLAs) at 24 hours per submission, totaling 7,920 annual burden hours for petition filers.
- External Speaker Requests: 3,900 at 10 Minutes: cost, low. FDA reports 3,900 external requests for FDA speakers annually, at an average burden of 0.17 hours (10 minutes) each, totaling 663 annual hours for requesters.
- No Capital or Ongoing Monetary Costs: benefit, low. The FDA states there are no capital costs or operating and maintenance costs associated with this collection of information.
- 10.19 Waiver Requests: 1 Response, 1 Hour: cost, low. FDA includes an estimate for Sec. 10.19 waiver/suspension/modification requests of 1 response annually at 1 hour of burden, noting that the agency has not received such requests but accounts for the possible burden.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-13534 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/06/2026-13534/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-13534 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-06/pdf/2026-13534.pdf)

## Related
- [Previous: 2026-13533, Agency Information Collection Activities; Proposed Collection; Comment Request;…](https://policyrisk.com/federal-register/2026-13533)
- [Next: 2026-13535, Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing and Immediate…](https://policyrisk.com/federal-register/2026-13535)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-13534 (as of 2026-07-13).
